Isabel Virchow
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Pre-existing systemic immune state and dynamic myeloid remodeling shape response to neoadjuvant PD-L1 blockade.
Journal: Journal for immunotherapy of cancer
Published: July 31, 2026
Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases-the PURPLE trial.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Accelerating eSource scale-up in oncology clinical trials: The i~HD Task Force initiative.
Journal: Cambridge prisms. Precision medicine
Published: June 17, 2025
ABO-Blood Group Associates With Survival Outcomes in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.
Journal: Thoracic cancer
Published: January 21, 2025
PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 26, 2024
Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapies.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 12, 2023
Impact of encorafenib on survival of patients with BRAFV600E-mutant metastatic colorectal cancer in a real-world setting.
Journal: Journal of cancer research and clinical oncology
Published: July 05, 2023
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO).
Journal: Oncology research and treatment
Published: November 24, 2022
SUVmax Above 20 in 18F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 08, 2022
A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma.
Journal: Journal of cancer research and clinical oncology
Published: September 06, 2022
Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols.
Journal: Oncology research and treatment
Published: August 15, 2022
Last Updated: 09/26/2026